通过支气管镜重新定义间质性肺疾病诊断:分子与影像创新
间质性肺疾病包含200多种疾病,传统依赖外科肺活检(死亡率1.7%-3.6%)。本综述探讨支气管镜新技术:经支气管冷冻肺活检死亡率0.0%-0.3%但诊断率降低;RNA测序基因组分类器特异性92%、敏感性68%;支气管内光学相干断层扫描分辨率超过高分辨率CT,与外科活检一致性好。
要点
- 经支气管冷冻肺活检死亡率0.0%-0.3%,低于外科肺活检的1.7%-3.6%。
- RNA测序基因组分类器识别普通型间质性肺炎特异性92%、敏感性68%。
- 支气管内光学相干断层扫描分辨率超过高分辨率CT,与外科活检一致性好。
核心结论
- 新兴支气管镜技术可能推动间质性肺疾病向精准医学转变,并保持优于当前有创标准的安全性。
研究设计与样本
- 综述,检索范围未明确报告。
主要发现
- 支气管肺泡灌洗液淋巴细胞百分比有助于区分过敏性肺炎与特发性肺纤维化,但敏感性和特异性有限。
- 经支气管肺冷冻活检死亡率0.0%-0.3%,诊断率低于外科肺活检。
- 经支气管活检RNA测序基因组分类器识别普通型间质性肺炎特异性92%、敏感性68%。
- 支气管肺泡灌洗液蛋白质组学和代谢组学揭示不同分子内型与生存轨迹差异。
- 支气管内光学相干断层扫描分辨率超过高分辨率CT,诊断纤维化模式与外科活检一致性好。
临床怎么用
- 支气管镜技术可提供较外科肺活检更安全的诊断途径,但需权衡诊断率。
- 基因组分类器高特异性有助于确认普通型间质性肺炎,但敏感性有限需结合其他信息。
- 光学相干断层扫描有望实时无创评估纤维化模式,辅助诊断。
局限性
- 支气管肺泡灌洗液细胞分析的敏感性和特异性有限。
- 经支气管冷冻肺活检诊断率低于外科肺活检。
- 基因组分类器敏感性有限(68%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC IMPORTANCE: Interstitial lung disease encompasses > 200 disorders characterized by lung parenchymal inflammation and fibrosis, presenting significant diagnostic challenges that often require invasive procedures with substantial morbidity and mortality risks. Diagnostic approaches have traditionally relied on surgical lung biopsy for definitive histopathologic evaluation, a procedure carrying a 1.7% to 3.6% mortality rate; however, its use has declined recently. Bronchoscopy offers a safer alternative that provides direct access to the lung microenvironment through bronchoalveolar lavage, tissue sampling, and airway visualization. REVIEW FINDINGS: Traditional bronchoscopic applications include cellular analysis of bronchoalveolar lavage fluid, which shows promise in differentiating hypersensitivity pneumonitis from idiopathic pulmonary fibrosis through lymphocyte percentages; however, limitations in sensitivity and specificity persist. Transbronchial lung cryobiopsy has emerged as a safer tissue sampling method with 0.0% to 0.3% mortality compared with surgical approaches, albeit with reduced diagnostic yield. Novel genomic classifiers using RNA sequencing from transbronchial biopsies demonstrate high specificity (92%) for identifying usual interstitial pneumonia patterns; however, sensitivity remains limited (68%). Advanced technologies including systems biology approaches through proteomics and metabolomics of bronchoalveolar lavage fluid reveal distinct molecular endotypes with differential survival trajectories, offering potential for personalized treatment strategies. Endobronchial optical coherence tomography provides real-time microscopic visualization with resolution exceeding high-resolution CT scan, enabling accurate diagnosis of fibrotic patterns with excellent concordance to surgical biopsy. SUMMARY: Emerging bronchoscopic technologies could represent a paradigm shift toward precision medicine in interstitial lung disease, potentially transforming diagnostic approaches while maintaining superior safety profiles compared with current invasive standards.
引用
- Mok A, Yamamoto S, Evans L, et al. Redefining Interstitial Lung Disease Diagnosis Through the Bronchoscope: Molecular and Imaging Innovations. Chest. 2026. PMID: 42413724. doi:10.1016/j.chest.2026.06.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。